Funding Opportunity RFA-DA-22-049 from the NIH Guide for Grants and Contracts. This FOA seeks applications for one Modeling and Economic Resource Center to support the HEAL D2A Innovation Projects. This center will provide expertise in a variety of simulation modeling and economic analyses and methods; utilize agent-based, predictive, geospatial or other simulation models to inform Innovation Project grantees about the potential public health impact of implementing different interventions, to support local implementation decisions; support the Innovation Projects in assessing costs and cost benefit associated with selected service delivery changes; develop costing tools that can be utilized by Innovation Grants to inform local decisions about the selection of interventions; and conduct original research applying state-of-the-art economic and simulation modeling expertise to understand and address the overdose crisis. This FOA runs in parallel with a set of companion FOAs supporting the other components of the HEAL D2A Program.

Funding Opportunity RFA-DA-22-050 from the NIH Guide for Grants and Contracts. This FOA solicits applications for one HEAL D2A Research Adoption Support Center to provide coordination and implementation support for the HEAL D2A Innovation Projects. The Centers primary purpose is to support funded projects in the selection and deployment of evidence-based practices to address identified needs. The Research Adoption Support Center will also provide logistical coordination for the initiative, engage key stakeholders, conduct rapid-turnaround studies in response to stakeholder-identified priorities, and conduct a formative evaluation of the HEAL D2A Program. This FOA runs in parallel with a set of companion FOAs supporting the other components of the HEAL D2A Program.

Funding Opportunity RFA-DA-22-051 from the NIH Guide for Grants and Contracts. As part of the NIH HEAL Initiative, the National Institute on Drug Abuse (NIDA) is releasing a set of interrelated RFAs to create the HEAL Data2Action (D2A) Program, a coordinated effort to promote the synthesis and real-world application of existing data to guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will address gaps in the delivery of evidence-based practices in each of the four pillars of the HHS Overdose Prevention Strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support. Separate FOAs are being issued to support multiple HEAL D2A Innovation Projects (RFA-DA-22-051); one HEAL D2A Data Infrastructure Support Center (RFA-DA-22-052); one HEAL D2A Research Adoption Support Center (RFA-DA-22-050); and one HEAL D2A Economics and Modeling Resource Center (RFA-DA-22-049). It is imperative that prospective applicants read all of these related RFAs to better understand the intended purpose and structure of the HEAL D2A Program. This FOA solicits applications for HEAL D2A Innovation Projects, which are phased awards intended to support local efforts, either within a single system or in cross-sector partnerships, to improve utilization of data to drive prediction and real-time proactive responses to the overdose crisis.

Funding Opportunity RFA-DA-22-052 from the NIH Guide for Grants and Contracts. This FOA seeks applications for a single Data Infrastructure Support Center to support the HEAL Data-to-Action (D2A) Innovation Grants. Key activities for this Support Center would include (1) providing tailored data infrastructure and resources to support the Innovation Grants in identifying, merging, and analyzing existing records or data systems to forecast service needs or gaps and to monitor improvements resulting from strategic implementation of new interventions; (2) facilitating access to key datasets that may be of broad interest to the D2A grantees; (3) providing data visualization support to enhance the utility of local data for decision-makers; and (4) compiling a library of measures that can be used across projects to measure service delivery and outcomes, e.g., along the opioid care cascade. This FOA runs in parallel with a set of companion FOAs supporting the other components of the HEAL D2A Program.

Funding Opportunity RFA-ES-22-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit grant applications that propose to: (1) support the maintenance and resource infrastructure enrichment for existing Environmental Epidemiology Cohorts (EECs) and to (2) enrich data management and data sharing activities to promote widespread data sharing and scientific collaborations to be inclusive of under-resourced minority-serving institutions and under-represented minority researchers. The ultimate goal is to maintain and maximize NIEHS cohort investments within the environmental epidemiology community by improving data collection on under-represented populations in environmental health studies, strengthening workforce diversity and promoting greater scientific collaboration.

£40,000-£50,000 depending on skills and experience: General Bioinformatics: Creative use of bioinformatics data coupled with scientific insight, you will provide novel information for genomics and target discovery projects. Reading, Berkshire

Funding Opportunity RFA-CA-22-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-22-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-22-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related Research Projects proposing to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-22-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P01 program projects. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-22-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P50 specialized centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-22-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U2C Resource-Related Multi-Component Projects and Centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-22-011 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research on human immunodeficiency virus (HIV)-associated cancers in low- and middle-income countries (LMICs) through the formation of collaborative partnerships between investigators in United States (U.S.) and investigators in LMICs. The FOA solicits applications for Specialized Center Cooperative Agreements (U54) for research on HIV-associated cancers from research institutions in the U.S. and LMICs. These partnerships are referred to as HIV-Associated Malignancy Research Centers (HAMRCs). Each proposed U54 HAMRC should be based upon partnerships involving at least one U.S. institution and institutions from at least two or more LMICs. Each HAMRC application is required to propose between two to three research projects that address questions in one scientific theme (e.g. viral-associated cancers) that is relevant to HIV-associated malignancies in LMICs or the U.S. The proposed projects may range, as appropriate, from basic research to translational efforts as well as to population and implementation studies. Mechanistic clinical studies that meet NIH's definition of a clinical trial will be allowed. In addition, the proposed U54 HAMRC must include an Administrative Core and a Developmental Core.

Competitive Salary: EMBL: We are looking for an experienced technical leader to develop and implement the technology strategy for our world-leading bioinformatics centre, as we Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: We have an exciting opportunity for a Grants Office Manager to lead our Grants team at EMBL's European Bioinformatics Institute (EMBL-EBI) based in Hi Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: In this role you will develop and manage the Ensembl Metazoa resource including our collaboration with VEuPathDB. As part of the Ensembl project, Ens Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: EMBL's European Bioinformatics Institute (EMBL-EBI) is seeking a Business Intelligence Analyst to provide a data-driven approach to support decision m Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: Training is a core activity across EMBL-EBI, involving almost every part of the organisation and coordinated by a team of ~30 people. The Training Tea Hinxton, Cambridgeshire, England

Experience in big data analysis including engineering of data ingestion pipelines, data modeling and data display. Comfortable working in cloud platforms.
From University of Wisconsin–Madison - Thu, 30 Dec 2021 00:59:10 GMT - View all Madison, WI jobs

£26,483-£45,359 - Salary dependent upon experience: Wellcome Sanger Institute: We are seeking a highly motivated bioinformatician or senior bioinformatician with experience in handling large genetic datasets to join the Martin... Cambridge, Cambridgeshire